---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-005359"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2026-09-02T20:45:37+00:00"
generated_at: "2026-09-02T20:48:09.116521+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# VolitionRx gets Lind waiver for unlimited ATM sales; conversion price set at $0.44

## Summary
- Lind consents to all ATM sales, removing $10M annual cap; waives related defaults and remedies under Purchase Agreement and Notes.
- Conversion price of $7.5M (May 2025) and $2.4M (Jan 2026) senior secured notes fixed at $0.44; warrant exercise price set at $0.572.
- Lind waives anti-dilution adjustments to Notes/Warrants for ATM sales after Aug 28, 2026; prior adjustments accounted for through that date.
- Company still must apply 20% of ATM proceeds (above exempted amounts) toward note repayment per Section 5.7 of Purchase Agreement.
- Waiver dated Sept 2, 2026; CEO Cameron Reynolds signed for VolitionRx.

## SEC filing metadata
- accession: 0001477932-26-005359
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2026-09-02T20:45:37+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793226005359/0001477932-26-005359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793226005359/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-005359
- JSON: https://secwatch.observer/filing/0001477932-26-005359.json
- Plain text: https://secwatch.observer/filing/0001477932-26-005359.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.